Karyopharm Files Chapter 11 to Pursue Merger with Ayrmid
Karyopharm has filed for Chapter 11 to pursue a merger with Ayrmid, securing $55 million in financing while continuing myeloma and myelofibrosis programs.
Already have an account? Sign in.